The Core Protein of the Syndecan-4 Ectodomain on Small Extracellular Vesicles Promotes Fusion with Endosomes
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c01494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Ryuta Yamanaka und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan. Hauptthemen laut MEDLINE: Syndecan-4, Endosomes, Membrane Fusion, Extracellular Vesicles. Die Arbeit nennt 67 Literaturangaben. Gefördert von: National Institute of Health Sciences, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Small extracellular vesicles (sEVs) can efficiently transfer payloads, such as nucleic acids, into the cytosol of cells. Endocytosis is a major pathway for the intracellular trafficking of sEVs, and some sEVs can fuse with late endosomes to release cargoes into the cytosol. Our understanding of the mechanisms regulating sEV composition heterogeneity and the molecular mechanism of the membrane fusion between sEVs and endosomes is limited. Here, we show that the core protein of the syndecan-4 ectodomain, the syndecan-4 ectodomain without heparan sulfate, on sEVs promoted this membrane fusion. In an in vitro lipid-mixing assay, the core protein of the syndecan-4 ectodomain was found to promote membrane fusion under the acidic conditions that are found in late endosomes. A recombinant core protein of the syndecan-4 ectodomain showed higher fusion activity than the domain with heparan sulfate. Conformational changes in the core protein were observed depending on the pH. The involvement of the core protein in membrane fusion was further investigated in a cell-based assay. Our results indicated that the conformation of the core protein was changed in late endosomes, which induced membrane fusion along with an increase in the membrane fluidity of the sEVs. This mechanism involving fusion proteins is similar to the mechanism of many virus infection systems. Syndecan-4, which is initially a glycoprotein containing heparan sulfate on the plasma membrane, has various functions, including cell adhesion and cell signaling, which are mainly thought to be facilitated through the heparan sulfate, and our results indicate the versatility of syndecan-4 actions in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.
- Division of Biochemistry, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki 210-9501, Japan.
ORCID-Profile: Yuki Takechi-Haraya, Norihito Shibata, Kumiko Sakai-Kato
Förderung
- National Institute of Health Sciences
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Yamanaka, R., Nagumo, H., Ema, R., Iwamoto, M., Sugiki, T., Takechi-Haraya, Y., Shibata, N., Kiyota, Y., Takeda-Shitaka, M., & Sakai-Kato, K. (2026). The Core Protein of the Syndecan-4 Ectodomain on Small Extracellular Vesicles Promotes Fusion with Endosomes. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01494
Vancouver
Yamanaka R, Nagumo H, Ema R, Iwamoto M, Sugiki T, Takechi-Haraya Y, et al. The Core Protein of the Syndecan-4 Ectodomain on Small Extracellular Vesicles Promotes Fusion with Endosomes. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01494
BibTeX
@article{Yamanaka2026,
author = {Yamanaka, Ryuta and Nagumo, Hiroki and Ema, Rumina and Iwamoto, Mana and Sugiki, Toshihiko and Takechi-Haraya, Yuki and Shibata, Norihito and Kiyota, Yasuomi and Takeda-Shitaka, Mayuko and Sakai-Kato, Kumiko},
title = {The Core Protein of the Syndecan-4 Ectodomain on Small Extracellular Vesicles Promotes Fusion with Endosomes},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c01494}
}
EUVIMED